share_log

Oppenheimer Maintains Outperform on Bionano Genomics, Lowers Price Target to $9

Benzinga Real-time News ·  Feb 6, 2023 07:38

Oppenheimer analyst Francois Brisebois maintains Bionano Genomics (NASDAQ:BNGO) with a Outperform and lowers the price target from $12 to $9.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment